SCHEMBL13450488

SCHEMBL13450488

C/C=C\C(=C/C)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14816929 0.82 ALDH1A1 (0.35)
SCHEMBL21845035 0.82 TSHR (0.32)
SCHEMBL14213401 0.78 GRIK1 (0.31)
SCHEMBL13971291 0.78 GRIK1 (0.31)
SCHEMBL18923945 0.78
SCHEMBL23029593 0.76
SCHEMBL13786730 0.76 ALDH1A1 (0.33)
SCHEMBL17928532 0.76
SCHEMBL11965884 0.76
SCHEMBL20646726 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10668090-B2 Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses thereof ZHEJIANG PALO ALTO PHARMACEUTICALS, INC (CN) 2020-06-02 US disclosed
US-20190125771-A1 LIVER SPECIFIC DELIVERY-BASED ANTIVIRAL PRODRUG NUCLEOSIDE CYCLOPHOSPHATE COMPOUND AND USES THEREOF ZHEJIANG PALO ALTO PHARMACEUTICALS,INC (CN) 2019-05-02 US disclosed
US-20190100792-A1 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME BATTELLE MEMORIAL INSTITUTE 2019-04-04 US disclosed
EP-3272747-A1 METHOD OF PREPARATION FOR LEDIPASVIR AND DERIVATIVE THEREOF, AND INTERMEDIATE COMPOUND FOR PREPARATION OF LEDIPASVIR Shanghai Forefront Pharmceutical Co., Ltd (CN) 2018-01-24 EP disclosed
EP-2513711-B1 METHODS FOR MAKING SILICONE HYDROGEL LENSES FROM WATER-BASED LENS FORMULATIONS NOVARTIS AG (CH) 2017-07-12 EP disclosed
US-9604910-B2 Composition of 5-nitrobenzoate derivatives as anti-metastatic agent that inhibits tumor cell-induced platelet aggregation CHANG GUNG UNIVERSITY (TW) 2017-03-28 US disclosed
WO-2013012848-A1 BENZAMIDES MERCK PATENT GMBH (DE) 2013-01-24 WO disclosed
EP-1389110-B1 INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND METHODS FOR IDENTIFYING THE SAME AVANIR PHARMACEUTICALS (US) 2010-03-24 EP disclosed
EP-1105413-B1 HEPATITIS C INHIBITOR TRI-PEPTIDES BOEHRINGER INGELHEIM CA LTD (CA) 2009-04-29 EP disclosed